IMBALANCED ACTIVATING AND INHIBITORY RECEPTORS ON CD56DIM NATURAL KILLER CELLS PREDICTS POOR OUTCOMES IN ACUTE MYELOID LEUKEMIA AFO Costa; V Kuznetsova; LO Marani; IA Lopes; LS Binelli; PS Scheucher; JL Schiavinato; MIA Madeira; KBB Pagnano; BK Duarte; ABF Glória; EM Rego; F Traina; R Welner; LL Figueiredo-Pontes;

NATURAL KILLER CELLS PHENOTYPE CORRELATES WITH TYROSINE KINASE INHIBITORS TREATMENT RESPONSE IN CHRONIC MYELOID LEUKEMIA PATIENTS LS Binelli; AFO Costa; LO Marani; IA Lopes; F Traina; LC Palma; PMM Garibaldi; LL Figueiredo-Pontes;

IMMUNOPHENOTYPIC SIGNATURE OF LEUKEMIA ARREST STAGE IS ASSOCIATED WITH NPM1/FLT3 MUTATIONAL PROFILE AND PROGNOSIS IN ACUTE MYELOID LEUKEMIA AG Carvalho; LO Marani; CAB Garcia; M Medeiros; LS Binelli; AFO Costa; EVB Ferreira; JLS Schiavinato; PS Scheucher; LL Figueiredo-Pontes;